Longboard Pharmaceuticals, Inc. Contracts & Agreements
31 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (2)
- Human Resources (13)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Uncategorized (2)
- Agreement and Plan of Merger, dated as of October 14, 2024, by and among Longboard Pharmaceuticals, Inc., H. Lundbeck A/S, Langkawi Corporation and Lundbeck LLC (Filed With SEC on October 15, 2024)
- Non-Employee Director Compensation Policy (Filed With SEC on August 1, 2024)
- Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (as amended and restated May 23, 2024) (Filed With SEC on August 1, 2024)
- Non-Voting Common Stock Purchase Agreement, dated March 26, 2024, by and between the Registrant and the Purchaser named therein (Filed With SEC on May 2, 2024)
- Form of grant notice and restricted stock unit agreement under the Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 12, 2024)
- Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 12, 2024)
- Underwriting Agreement by and among the Company, Cantor Fitzgerald & Co. and Citigroup Global Markets Inc. dated January 3, 2024 (Filed With SEC on January 4, 2024)
- Non-Employee Director Compensation Policy, as amended and restated May 25, 2023 (Filed With SEC on August 3, 2023)
- Underwriting Agreement by and among the Company, Evercore Group L.L.C. and Cantor Fitzgerald & Co. dated February 7, 2023 (Filed With SEC on February 8, 2023)
- Second Amendment to License Agreement by and between the Registrant and Arena Pharmaceuticals, Inc., dated September 13, 2022 (Filed With SEC on November 3, 2022)
- January 2022 amendment to Arena License Agreement (Filed With SEC on March 3, 2022)
- Description of Capital Stock (Filed With SEC on March 3, 2022)
- Amended and Restated Employment Agreement by and between the registrant and Kevin R. Lind, dated March 1, 2021 (Filed With SEC on March 8, 2021)
- Exchange Agreement by and among the registrant and the stockholders listed therein, dated March 5, 2021 (Filed With SEC on March 8, 2021)
- Amended and Restated Offer Letter by and between the registrant and Brandi L. Roberts, dated March 1, 2021 (Filed With SEC on March 8, 2021)
- Amended and Restated Offer Letter by and between the registrant and Philip Perera, M.D., dated March 1, 2021 (Filed With SEC on March 8, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on March 8, 2021)
- Longboard Pharmaceuticals, Inc. Performance Bonus Plan (Filed With SEC on March 8, 2021)
- Longboard Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on March 8, 2021)
- Forms of grant notice, stock option agreement and notice of exercise under the Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 8, 2021)
- Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 8, 2021)
- Forms of restricted stock award grant notice and restricted stock award terms and conditions under the Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 8, 2021)
- Form of Common Stock Certificate (Filed With SEC on March 8, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 8, 2021)
- Investors Rights Agreement by and among the registrant and certain of its stockholders, dated October 27, 2020 (Filed With SEC on February 19, 2021)
- Services Agreement by and between the registrant and Arena Pharmaceuticals, Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)
- Royalty Purchase Agreement by and among the registrant, Arena Pharmaceuticals, Inc. and 356 Royalty Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)
- License Agreement by and between the registrant and Arena Pharmaceuticals, Inc., dated October 27, 2020 (Filed With SEC on February 19, 2021)
- Form of Indemnification Agreement by and between the registrant and each director and executive officer (Filed With SEC on February 19, 2021)
- Forms of grant notice, stock option agreement and notice of exercise under the Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on February 19, 2021)
- Longboard Pharmaceuticals, Inc. 2020 Equity Incentive Plan (Filed With SEC on February 19, 2021)
